• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Bend Research launches biotherapeutics development initiative

Bend Research launches biotherapeutics development initiative

March 26, 2012
CenterWatch Staff

Bend Research, an independent drug-formulation development and manufacturing company based in Bend, Ore., has launched an initiative to expand its scientific and engineering expertise into biotherapeutics.

Bend Research will partner with clients to develop and optimize pharmaceutical engineering processes and technologies by coupling fundamental cellular processes with the optimal cell environment for each phase of production.

“The campaign is grounded in science and engineering fundamentals, with a focus on applying macro engineering approaches to leverage an understanding of complex cell-biology,” said Dr. Lisa Graham, senior vice president, Bend Research. “We’ve validated this approach in our small-molecules business and we’re now uniquely positioned to bring this valuable experience to the broader biotherapeutics market.”

The initiative builds upon an exclusive relationship with Pfizer of nearly seven years, in which Bend Research develop new tools and models to advance candidates in the Pfizer biotherapeutics pipeline. Through those projects, innovative tools were developed that streamline production within existing plants and provide other cost-savings opportunities during the design of new plants.

In the past, Bend Research has provided a wide range of bioprocessing services and capabilities to help clients advance biotherapeutic products and processes, capitalizing on the company’s experience in process development, analytical sciences and formulation science. This includes comprehensive development methodologies, individual tools and models, upstream and downstream bioprocessing solutions, computational modeling at multiple scales and prototype engineering.

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing